The collective integration of 5′-tRF-GlyGCC with conventional markers such as CEA and CA199 promises enhanced diagnostic efficacy within the CRC diagnostic landscape (Wu et al., 2021). The gene discussed is CEACAM5; the disease is colorectal carcinoma.